These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6894803)

  • 1. [HL-A system and Graves' disease. Predominance of the DRW3 antigen].
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    Rev Med Interne; 1980; 1(2):163-70. PubMed ID: 6894803
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA and Graves' disease: an association with HLA-DRw3.
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
    Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
    Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HLA DRW3 and Graves' disease (author's transl)].
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    Ann Endocrinol (Paris); 1980; 41(1):70-2. PubMed ID: 6893111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
    Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
    J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of human leukocyte D locus related antigens in Graves' disease.
    Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
    J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and Graves' disease in Black South Africans.
    Kalk WJ; Maier G; van Drimellen M; Levin J; Reinach SG
    Tissue Antigens; 1983 Jul; 22(1):7-15. PubMed ID: 6604348
    [No Abstract]   [Full Text] [Related]  

  • 8. Japanese Graves' disease: association with HLA-Bw46.
    Naito S; Sasaki H; Arakawa K
    Endocrinol Jpn; 1987 Oct; 34(5):685-8. PubMed ID: 3436299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA with Graves' disease in Chinese.
    Tong ZH; Zhu G; Yan LX; Zhu J; Feng YG; Xu G
    Chin Med J (Engl); 1987 Apr; 100(4):296-8. PubMed ID: 3115694
    [No Abstract]   [Full Text] [Related]  

  • 10. HL-A antigens in Graves' disease and Hashimoto's thyroiditis.
    Farid NR; Barnard J; Kutas C; Noel EP; Marshall WH
    Int Arch Allergy Appl Immunol; 1975; 49(6):837-42. PubMed ID: 1242384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
    Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
    J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of relapse in hyperthyroid Graves' disease.
    McGregor AM; Smith BR; Hall R; Petersen MM; Miller M; Dewar PJ
    Lancet; 1980 May; 1(8178):1101-3. PubMed ID: 6103438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
    Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese.
    Hawkins BR; Ma JT; Lam KS; Wang CC; Yeung RT
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):245-52. PubMed ID: 3865750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I and II antigens in South African blacks with Graves' disease.
    Omar MA; Hammond MG; Desai RK; Motala AA; Aboo N; Seedat MA
    Clin Immunol Immunopathol; 1990 Jan; 54(1):98-102. PubMed ID: 2293909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
    Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the HL-A system in Basedow's disease (author's transl)].
    Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
    Ann Endocrinol (Paris); 1976; 37(2):111-2. PubMed ID: 1036872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotrophin-binding inhibitory immunoglobulins and HLA-DRW3-two prognostic factors in Graves' disease.
    Teng CS; Yeung RT; Kawa A; Nakamura S; Nomoto K; Arima N; Koreeda N; Tsuji K; Ho PW
    Aust N Z J Med; 1981 Aug; 11(4):383-5. PubMed ID: 6118115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.